Publication of 2023 financial results and operating update
Financial highlights include successful public rights offering and the subsequent 2024 buyback of all convertible bonds,…
Financial highlights include successful public rights offering and the subsequent 2024 buyback of all convertible bonds,…
BioEcho Life Sciences, the biotechnology company supplying fast and sustainable nucleic acid extraction technologies, ha…
Summary: ADLINK is expanding its market penetration and presence in EMEA through a strategic partnership with broadlin…
Two of six patients receiving NOX-A12 in combination with bevacizumab and radiotherapy exceeded 24-month survival si…
Tyenne® is the first tocilizumab biosimilar by Fresenius Kabi, an operating company of Fresenius, with an intravenous an…
CeGaT, a global provider of genetic diagnostics and sequencing services based in Tübingen, Germany, is celebrating sever…
The US trade magazine "Healthcare Tech Outlook" recently named ibidi GmbH one of the ten best European manufacturers of…
PELOBIOTECH GmbH, a leader in the field of biotechnology, announces a strategic partnership with HVD Life Science Vertri…
DKSH Business Unit Technology has expanded its partnership with LUM GmbH, a leading provider of world-class instruments…
Fast Track designation awarded by the FDA serves as an external validation of the potential of NOX-A12 for unmet need in…